CN111603427A - Whitening and relieving mask - Google Patents
Whitening and relieving mask Download PDFInfo
- Publication number
- CN111603427A CN111603427A CN202010497538.3A CN202010497538A CN111603427A CN 111603427 A CN111603427 A CN 111603427A CN 202010497538 A CN202010497538 A CN 202010497538A CN 111603427 A CN111603427 A CN 111603427A
- Authority
- CN
- China
- Prior art keywords
- extract
- abalone
- whitening
- essential oil
- mask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 46
- 239000000284 extract Substances 0.000 claims abstract description 237
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 52
- 239000000341 volatile oil Substances 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 244000075850 Avena orientalis Species 0.000 claims abstract description 33
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 33
- 241000234435 Lilium Species 0.000 claims abstract description 32
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 32
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 32
- 241000132012 Atractylodes Species 0.000 claims abstract description 31
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 31
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 31
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 31
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 31
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 31
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 31
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 30
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 30
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 30
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims abstract description 30
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims abstract description 30
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims abstract description 30
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 30
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 30
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims abstract description 30
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 30
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 30
- 229950006780 n-acetylglucosamine Drugs 0.000 claims abstract description 30
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 30
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 26
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 26
- 239000011718 vitamin C Substances 0.000 claims abstract description 26
- 239000004744 fabric Substances 0.000 claims abstract description 23
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims abstract description 21
- 229940051810 licorice root extract Drugs 0.000 claims abstract description 21
- 235000020725 licorice root extract Nutrition 0.000 claims abstract description 21
- 241001633680 Polygonatum odoratum Species 0.000 claims abstract description 8
- 241000756042 Polygonatum Species 0.000 claims description 24
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 22
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 22
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 21
- 235000011477 liquorice Nutrition 0.000 claims description 21
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 17
- 240000009022 Smilax rotundifolia Species 0.000 claims description 16
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 16
- 230000001815 facial effect Effects 0.000 claims description 11
- 235000007685 Pleurotus columbinus Nutrition 0.000 claims description 9
- 240000001462 Pleurotus ostreatus Species 0.000 claims description 9
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 4
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 claims description 4
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims description 2
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 28
- 239000006210 lotion Substances 0.000 abstract description 2
- 239000000686 essence Substances 0.000 description 50
- 210000003491 skin Anatomy 0.000 description 19
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 14
- 102000003425 Tyrosinase Human genes 0.000 description 13
- 108060008724 Tyrosinase Proteins 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- 240000007087 Apium graveolens Species 0.000 description 5
- 235000002764 Apium graveolens Nutrition 0.000 description 5
- 239000001387 apium graveolens Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 208000035824 paresthesia Diseases 0.000 description 3
- 241000092665 Atractylodes macrocephala Species 0.000 description 2
- HJXMNVQARNZTEE-UHFFFAOYSA-N Butylphthalide Chemical compound C1=CC=C2C(CCCC)OC(=O)C2=C1 HJXMNVQARNZTEE-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 241000208306 Apium Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 240000008632 Cota tinctoria Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229950005197 butylphthalide Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- -1 hydroxy free radical Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a whitening and relieving mask which comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: the skin whitening and soothing lotion is prepared from, by weight, 1-3% of abalone extract, 0.1-0.9% of abalone essential oil, 0.1-1.5% of bighead atractylodes rhizome extract, 0.5-0.9% of oat kernel extract, 0.1-3% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.1-0.7% of polygonatum odoratum extract, 0.1-0.5% of licorice root extract, 0.6-1% of chamomile extract, 1-5% of tranexamic acid, 3-10% of nicotinamide, 1-5% of sodium hyaluronate, 1-5% of oligopeptide, 0.1-3% of N-acetylglucosamine, 1-4% of vitamin C, 1-5% of ferulic acid, 2-5% of beta-glucan and the balance of water, wherein the components can jointly play a whitening and soothing effects, and the effective utilization of local abalone is realized.
Description
Technical Field
The invention relates to the field of cosmetics, and particularly relates to a whitening and relieving mask.
Background
With the rapid development of modern economy, the social pressure is increased, the diet is irregular, the influence of environmental quality is added, obviously, the secretion of melanin of people is more and more, and the strong ultraviolet irradiation easily causes uneven skin color, dark skin color and even spot formation.
People use more and more time and funds to perform self investment and image management, more and more people are not simply meeting the basic skin care of healthy skin and want to further pursue white skin, but the traditional whitening products have the obvious effect that heavy metals exceed the standard and are not suitable for long-term use. The inhibition of melanin secretion is mainly based on two aspects of antioxidation and tyrosinase activity inhibition, so the problems of antioxidation and tyrosinase activity inhibition need to be solved to achieve the purpose of whitening.
The abalone is a special agricultural product of Shandong chapter dun, and is always a main economic source for local vegetable growers, the current eating mode of the abalone is mainly fresh food, the eating parts are mainly one to two and a half parts from inside to outside, other large amount of abalone stems and leaves are treated by waste, the rest parts are mainly discarded in rural areas or fed to livestock, the economic value cannot be well played, and the problem of environmental pollution also exists. Through research, the extract of the abalone contains a large amount of flavonoid components, the flavonoid components have an antioxidant effect, can clear hydroxyl free radicals and inhibit lipid peroxidation, and the essential oil of the abalone contains terpenes and aromatic components, has an antibacterial effect and a nerve soothing effect, so that the applicant considers that the extract is combined into a skin care product.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: the essence in the mask contains multiple active ingredients such as the abalone extract, the abalone essential oil, the bighead atractylodes rhizome extract, the oat kernel extract, the glycyrrhiza glabra extract, the lily extract, the polygonatum extract, the liquorice extract, the chamomile extract and the like, the ingredients can resist oxidation and inhibit tyrosinase activity, and the whitening and soothing effects are achieved.
In order to solve the technical problems, the technical scheme of the invention is as follows: the whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 1-3% of abalone extract, 0.1-0.9% of abalone essential oil, 0.1-1.5% of bighead atractylodes rhizome extract, 0.5-0.9% of oat kernel extract, 0.1-3% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.1-0.7% of polygonatum extract, 0.1-0.5% of licorice root extract, 0.6-1% of chamomile extract, 1-5% of tranexamic acid, 3-10% of nicotinamide, 1-5% of sodium hyaluronate, 1-5% of oligopeptide, 0.1-3% of N-acetylglucosamine, 1-4% of vitamin C, 1-5% of ferulic acid, 2-5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 2-3% of abalone extract, 0.1-0.5% of abalone essential oil, 0.7-1.2% of bighead atractylodes rhizome extract, 0.6-0.8% of oat kernel extract, 0.2-1.1% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.3-0.6% of polygonatum extract, 0.2-0.4% of licorice extract, 0.6-0.8% of chamomile extract, 2-4% of tranexamic acid, 3-6% of nicotinamide, 1-2% of sodium hyaluronate, 1-2% of oligopeptide, 0.1-1.8% of N-acetylglucosamine, 1-2% of vitamin C, 1.1-1.9% of ferulic acid, 2-2.5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 1-2% of abalone extract, 0.2-0.3% of abalone essential oil, 0.2-0.7% of bighead atractylodes rhizome extract, 0.5-0.6% of oat kernel extract, 0.4-1.0% of glabrous licorice root extract, 0.6-0.8% of lily extract, 0.2-0.6% of polygonatum odoratum extract, 0.1-0.3% of licorice root extract, 0.8-0.9% of chamomile extract, 2-3% of tranexamic acid, 8-10% of nicotinamide, 1-3% of sodium hyaluronate, 3-5% of oligopeptide, 0.15-2% of N-acetylglucosamine, 2-3% of vitamin C, 3-5% of ferulic acid, 3-5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 1-2% of abalone extract, 0.5-0.9% of abalone essential oil, 0.8-1.0% of bighead atractylodes rhizome extract, 0.8-0.9% of oat kernel extract, 0.4-1.0% of glycyrrhiza glabra extract, 0.6-0.8% of lily extract, 0.2-0.6% of polygonatum odoratum extract, 0.1-0.3% of liquorice extract, 0.8-0.9% of chamomile extract, 2-3% of tranexamic acid, 3-4% of nicotinamide, 1-3% of sodium hyaluronate, 2-3% of oligopeptide, 0.15-2% of N-acetylglucosamine, 1-2% of vitamin C, 1.1-3% of ferulic acid, 2-2.5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 2-3% of abalone extract, 0.3-0.5% of abalone essential oil, 1.0-1.5% of bighead atractylodes rhizome extract, 0.6-0.8% of oat kernel extract, 0.2-0.4% of glabrous licorice root extract, 0.5-0.6% of lily extract, 0.2-0.3% of polygonatum odoratum extract, 0.4-0.5% of licorice root extract, 0.8-1% of chamomile extract, 4-5% of tranexamic acid, 4-6% of nicotinamide, 2-3% of sodium hyaluronate, 3-5% of oligopeptide, 2-3% of N-acetylglucosamine, 3-4% of vitamin C, 1.1-3% of ferulic acid, 2.5-3% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.1% of abalone essential oil, 1.5% of bighead atractylodes rhizome extract, 0.5% of oat kernel extract, 3% of glabrous greenbrier rhizome extract, 0.5% of lily bulb extract, 0.7% of fragrant solomonseal rhizome extract, 0.1% of liquorice extract, 0.6% of chamomile extract, 1% of tranexamic acid, 10% of nicotinamide, 1% of sodium hyaluronate, 5% of oligopeptide, 3% of N-acetylglucosamine, 4% of vitamin C, 5% of ferulic acid, 5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.5% of abalone essential oil, 1.2% of bighead atractylodes rhizome extract, 0.8% of oat kernel extract, 0.2% of glabrous greenbrier rhizome extract, 0.9% of lily bulb extract, 0.6% of fragrant solomonseal rhizome extract, 0.2% of liquorice extract, 0.8% of chamomile extract, 4% of tranexamic acid, 6% of nicotinamide, 2% of sodium hyaluronate, 1% of oligopeptide, 0.1% of N-acetylglucosamine, 2% of vitamin C, 1.9% of ferulic acid, 2.5% of beta-glucan and the balance of water.
Preferably, the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.5% of abalone essential oil, 1.0% of bighead atractylodes rhizome extract, 0.9% of oat kernel extract, 0.4% of glabrous greenbrier rhizome extract, 0.6% of lily bulb extract, 0.2% of fragrant solomonseal rhizome extract, 0.3% of liquorice extract, 0.9% of chamomile extract, 3% of tranexamic acid, 3% of nicotinamide, 3% of sodium hyaluronate, 3% of oligopeptide, 0.15% of N-acetylglucosamine, 1% of vitamin C, 1.1% of ferulic acid, 2% of beta-glucan and the balance of water.
Preferably, the Pleurotus Ostreatus extract and Pleurotus Ostreatus essential oil are both obtained from Pleurotus Ostreatus in Shandong province.
Preferably, the mask cloth is one of non-woven fabrics, tencel, plant fibers and superfine fiber film cloth.
After the technical scheme is adopted, the invention has the effects that: the essence of the whitening and soothing mask comprises a abalone extract, an abalone essential oil, a bighead atractylodes rhizome extract, an oat kernel extract, a glabrous licorice root extract, a lily extract, a fragrant solomonseal rhizome extract, a licorice root extract, a chamomile extract, tranexamic acid, nicotinamide, sodium hyaluronate and the like, has the effects of whitening and soothing the skin, can effectively block the formation of melanin, accelerates the shedding of stratum corneum, and increases the toughness of the skin, so that the mask has the effects of whitening, calming and soothing. .
The components of the essence of the whitening and soothing mask are explained as follows:
the extract of herba Apii Graveolentis (Apium graveolens) contains abundant flavonoids, which have antioxidant effect, and can scavenge hydroxy free radical and inhibit lipid peroxidation;
the essential oil of abalone (Apium GRAVEOLEUS) contains terpenes and aromatic components, has antibacterial effect, and nerve relieving effect, and the butyl phthalide contained in the essential oil of abalone has neuroprotective effect;
the extract of chamomile (Anthemis TINCTORIA) contains bisabolol, and can increase skin permeability;
atractylodis rhizoma (Atractylodes MACROCEPHALA) extract, herba Avenae Fatuae (AVENA SATIVA) extract, Glycyrrhrizae RADIX (Glycyrrhiza Glabra) extract, Bulbus Lilii (BULBUS LILII) extract, rhizoma Polygonati Odorati (FRAGRANTLANDPICK) extract and Glycyrrhrizae RADIX (RADIX Glycyrrhiza) extract have skin whitening effect;
the tranexamic acid, the nicotinamide, the oligopeptide, the N-acetylglucosamine and the vitamin C can effectively block the formation of melanin;
ferulic acid has slight exfoliation effect on stratum corneum;
the sodium hyaluronate and the beta-glucan have the effect of relieving, and can also improve the water retention and moisture retention capacity of the skin, so that the skin is more transparent.
Detailed Description
The present invention is described in further detail below with reference to specific examples.
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 1-3% of abalone extract, 0.1-0.9% of abalone essential oil, 0.1-1.5% of bighead atractylodes rhizome extract, 0.5-0.9% of oat kernel extract, 0.1-3% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.1-0.7% of polygonatum extract, 0.1-0.5% of licorice root extract, 0.6-1% of chamomile extract, 1-5% of tranexamic acid, 3-10% of nicotinamide, 1-5% of sodium hyaluronate, 1-5% of oligopeptide, 0.1-3% of N-acetylglucosamine, 1-4% of vitamin C, 1-5% of ferulic acid, 2-5% of beta-glucan and the balance of water.
The Pleurotus Ostreatus extract and Pleurotus Ostreatus essential oil are both obtained from Pleurotus Ostreatus in Shandong province.
The facial mask cloth is one of non-woven fabric, silk, plant fiber and superfine fiber membrane cloth.
Example 1
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.1% of abalone essential oil, 1.5% of bighead atractylodes rhizome extract, 0.5% of oat kernel extract, 3% of glabrous greenbrier rhizome extract, 0.5% of lily bulb extract, 0.7% of fragrant solomonseal rhizome extract, 0.1% of liquorice extract, 0.6% of chamomile extract, 1% of tranexamic acid, 10% of nicotinamide, 1% of sodium hyaluronate, 5% of oligopeptide, 3% of N-acetylglucosamine, 4% of vitamin C, 5% of ferulic acid, 5% of beta-glucan and the balance of water.
In this embodiment, the preparation method of the abalone extract includes the following steps: adding fresh Apium graveolens leaves into an extraction tank, adding 40 vol% ethanol water solution at a material-to-liquid ratio of 1:15(kg/L), maintaining the temperature at 80 deg.C, heating and refluxing for 1h to obtain an Apium graveolens extract solution, concentrating under reduced pressure at 57 deg.C under-0.01 Mpa to obtain an extract, and freeze drying to obtain an Apium graveolens extract. The preparation methods of the atractylodes macrocephala koidz extract, the oat kernel extract, the glycyrrhiza glabra extract, the lily extract, the polygonatum odoratum extract, the liquorice extract, the chamomile extract and the like are similar to the preparation method of the abalone extract.
The preparation method of the essential oil of abalone comprises the following steps: adding fresh Apium graveolens leaf into volatile oil extractor, adding water solution at a ratio of 1:3(kg/L), maintaining the temperature at 100 deg.C, and extracting for 90 min.
In the embodiment, the selected water is mineral water, preferably, the head of soup hot spring which is available at Yiyi is used, the head of soup hot spring is one of the four earliest natural first-class hot springs in China, has a history of 2800 years, and the hot spring water contains abundant minerals and trace elements and has the effects of sterilization and inflammation diminishing.
The mask cloth is non-woven fabric, and of course, one of silk, plant fiber and superfine fiber film cloth can be adopted according to the requirement of water absorption.
The preparation method of the essence comprises the following steps:
adding the abalone extract, the abalone essential oil, the bighead atractylodes rhizome extract, the oat kernel extract, the glabrous licorice root extract, the lily extract, the polygonatum extract, the liquorice extract, the chamomile extract, the tranexamic acid, the nicotinamide, the sodium hyaluronate, the oligopeptide, the N-acetylglucosamine, the vitamin C, the ferulic acid and the beta-glucan into water, uniformly stirring, and filtering through 200-mesh filter cloth to obtain clear liquid.
The essence solution may also contain herba Saxifragae extract, folium Vaccinii Vitis-idaeae extract, lignum Pyrolae extract, Aloe extract, Chlorella extract, Lentinus Edodes extract, etc.
Example 2
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 3% of abalone extract, 0.9% of abalone essential oil, 0.1% of bighead atractylodes rhizome extract, 0.9% of oat kernel extract, 0.1% of glabrous greenbrier rhizome extract, 0.9% of lily bulb extract, 0.1% of fragrant solomonseal rhizome extract, 0.5% of liquorice extract, 1% of chamomile extract, 5% of tranexamic acid, 3% of nicotinamide, 5% of sodium hyaluronate, 1% of oligopeptide, 0.1% of N-acetylglucosamine, 1% of vitamin C, 1% of ferulic acid, 2% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 3
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.5% of abalone essential oil, 1.2% of bighead atractylodes rhizome extract, 0.8% of oat kernel extract, 0.2% of glabrous greenbrier rhizome extract, 0.9% of lily bulb extract, 0.6% of fragrant solomonseal rhizome extract, 0.2% of liquorice extract, 0.8% of chamomile extract, 4% of tranexamic acid, 6% of nicotinamide, 2% of sodium hyaluronate, 1% of oligopeptide, 0.1% of N-acetylglucosamine, 2% of vitamin C, 1.9% of ferulic acid, 2.5% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 4
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 3% of abalone extract, 0.1% of abalone essential oil, 0.7% of bighead atractylodes rhizome extract, 0.6% of oat kernel extract, 1.1% of glabrous greenbrier rhizome extract, 0.5% of lily bulb extract, 0.3% of fragrant solomonseal rhizome extract, 0.4% of liquorice extract, 0.6% of chamomile extract, 2% of tranexamic acid, 3% of nicotinamide, 1% of sodium hyaluronate, 2% of oligopeptide, 1.8% of N-acetylglucosamine, 1% of vitamin C, 1.1% of ferulic acid, 2% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 5
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.2% of abalone essential oil, 0.7% of bighead atractylodes rhizome extract, 0.6% of oat kernel extract, 1.1% of glabrous greenbrier rhizome extract, 0.6% of lily bulb extract, 0.2% of fragrant solomonseal rhizome extract, 0.3% of liquorice extract, 0.8% of chamomile extract, 2% of tranexamic acid, 8% of nicotinamide, 1% of sodium hyaluronate, 3% of oligopeptide, 2% of N-acetylglucosamine, 3% of vitamin C, 5% of ferulic acid, 5% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 6
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.3% of abalone essential oil, 0.2% of bighead atractylodes rhizome extract, 0.5% of oat kernel extract, 0.4% of glabrous greenbrier rhizome extract, 0.8% of lily bulb extract, 0.6% of fragrant solomonseal rhizome extract, 0.1% of liquorice extract, 0.9% of chamomile extract, 3% of tranexamic acid, 10% of nicotinamide, 3% of sodium hyaluronate, 5% of oligopeptide, 0.15% of N-acetylglucosamine, vitamin C2%, 3% of ferulic acid, 5% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 7
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.5% of abalone essential oil, 1.0% of bighead atractylodes rhizome extract, 0.9% of oat kernel extract, 0.4% of glabrous greenbrier rhizome extract, 0.6% of lily bulb extract, 0.2% of fragrant solomonseal rhizome extract, 0.3% of liquorice extract, 0.9% of chamomile extract, 3% of tranexamic acid, 3% of nicotinamide, 3% of sodium hyaluronate, 3% of oligopeptide, 0.15% of N-acetylglucosamine, 1% of vitamin C, 1.1% of ferulic acid, 2% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 8
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.9% of abalone essential oil, 0.8% of bighead atractylodes rhizome extract, 0.8% of oat kernel extract, 1.0% of glabrous greenbrier rhizome extract, 0.8% of lily bulb extract, 0.6% of fragrant solomonseal rhizome extract, 0.1% of liquorice extract, 0.8% of chamomile extract, 2% of tranexamic acid, 4% of nicotinamide, 1% of sodium hyaluronate, 2% of oligopeptide, 2% of N-acetylglucosamine, 2% of vitamin C, 3% of ferulic acid, 2.5% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 9
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 3% of abalone extract, 0.3% of abalone essential oil, 0.1% of bighead atractylodes rhizome extract, 0.8% of oat kernel extract, 0.4% of glabrous greenbrier rhizome extract, 0.5% of lily bulb extract, 0.3% of fragrant solomonseal rhizome extract, 0.5% of liquorice extract, 1% of chamomile extract, 5% of tranexamic acid, 4% of nicotinamide, 2% of sodium hyaluronate, 5% of oligopeptide, 3% of N-acetylglucosamine, 3% of vitamin C, 3% of ferulic acid, 3% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Example 10
The whitening and relieving mask comprises essence and mask base cloth, wherein the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.5% of abalone essential oil, 1.5% of bighead atractylodes rhizome extract, 0.6% of oat kernel extract, 0.2% of glabrous greenbrier rhizome extract, 0.6% of lily bulb extract, 0.2% of fragrant solomonseal rhizome extract, 0.4% of liquorice extract, 0.8% of chamomile extract, 4% of tranexamic acid, 6% of nicotinamide, 3% of sodium hyaluronate, 3% of oligopeptide, 2% of N-acetylglucosamine, 4% of vitamin C, 1.1% of ferulic acid, 2.5% of beta-glucan and the balance of water.
In this embodiment, the preparation methods of the abalone extract, the abalone essential oil, the essence and other extracts are similar to those in embodiment 1, and are not described herein again.
Comfort test
Testing the population:
100 volunteers are selected for trial, the patients are 15-26 years old, the symptoms are mainly manifested by the uncomfortable phenomena of facial red blood streak, pruritus, stabbing pain and the like, 100 subjects are randomly divided into 10 groups, and each group respectively uses the mask component of the embodiment.
Note that: the person chooses not to take antihistamine or immunosuppressant within the last week.
The test method comprises the following steps:
after cleaning the face at night every day, the mask was spread and applied for 15min, and then removed, so that one sheet was used at intervals of 2 days for 10 cycles (30 days), and the results were observed. The skin is normally protected according to the usual skin care steps without changing or simplifying the skin care steps and additionally using other brands of facial masks,
and (3) testing the effect:
TABLE 1 comfort Performance test results Table
The effect is weak: the facial redness is relieved, and the tingling sensation is weakened but existed;
has the following effects: the redness of the face is relieved, and the skin prickling sensation is weakened;
the effect is obvious: the redness of the face except the two cheeks disappears, the tingling sensation disappears, the moisture content of the skin is increased (more than 15 percent), and the moisture loss value through the epidermis is 11-14 percent;
the effect is remarkable: the redness of the face disappears, the skin is fair, the tingling sensation disappears, the moisture content of the skin is increased (more than 15 percent), and the moisture loss value of the skin is 7-10 percent.
According to the test results, the average effect of 10 volunteers selected in each embodiment is finally obtained, and according to the test results, the skin problems of red blood streak, pruritus, stabbing pain and the like are all relieved and solved to a certain extent by using the facial masks of the ten embodiments for 100 volunteers, so that the facial masks are worthy of being popularized as relieving products.
(II) whitening test
The whitening effect is mainly achieved by inhibiting the activity of tyrosinase so as to prevent the formation of melanin, thereby achieving the effect of whitening the skin.
The whitening test principle is as follows:
melanin is actually an amino acid derivative, the melanine pigment can activate tyrosinase to form melanin when external environmental stimulation is received, the tyrosinase is the most important factor in the formation process of the melanin, and the effect of whitening can be achieved by inhibiting the activity of the tyrosinase.
The essences of examples 1 to 10 were subjected to tyrosinase activity inhibition experiments, and the inhibition rate of tyrosinase activity was measured to evaluate whitening effects.
The whitening test method comprises the following steps:
adding corresponding reaction liquid into samples respectively, shaking and mixing uniformly, preheating for 10min at 37 ℃, then adding tyrosinase solution into each test tube respectively, reacting for 5min at 37 ℃, quickly transferring into a cuvette, and measuring an absorbance value at 475nm to represent the efficacy of the inhibitor by an inhibitor concentration (IC50) which causes the tyrosinase activity to be reduced by 50%.
And (3) a whitening test result:
TABLE 2 Melanin inhibitory Effect
| Tyrosinase inhibitory concentration (IC50) | |
| Example 1 | 0.209±0.1 |
| Example 2 | 0.213±0.2 |
| Example 3 | 0.258±0.1 |
| Example 4 | 0.261±0.3 |
| Example 5 | 0.227±0.1 |
| Example 6 | 0.215±0.1 |
| Example 7 | 0.206±0.2 |
| Example 8 | 0.233±0.1 |
| Example 9 | 0.201±0.3 |
| Example 10 | 0.229±0.1 |
| Arbutin (positive control) | 0.193±0.1 |
According to the test results in table 2, the mask essences described in examples 1 to 10 have higher inhibitory concentration (IC50) on tyrosinase activity than the positive control arbutin.
From the test results, the facial mask essence of the 10 embodiments shows good whitening effects to different degrees, and is worthy of popularization as a whitening product.
The essence components in the application can be matched with surfactants, emulsifiers and silicone grease components to form various product forms such as cream, lotion, essence, facial cleanser and the like.
The above-mentioned embodiments are merely descriptions of the preferred embodiments of the present invention, and are not intended to limit the scope of the present invention, and various modifications and alterations made to the technical solution of the present invention without departing from the spirit of the present invention are intended to fall within the scope of the present invention defined by the claims.
Claims (10)
1. The whitening and relieving mask is characterized by comprising the following components: the facial mask comprises essence and facial mask base cloth, wherein the essence comprises the following components in percentage by weight: 1-3% of abalone extract, 0.1-0.9% of abalone essential oil, 0.1-1.5% of bighead atractylodes rhizome extract, 0.5-0.9% of oat kernel extract, 0.1-3% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.1-0.7% of polygonatum extract, 0.1-0.5% of licorice root extract, 0.6-1% of chamomile extract, 1-5% of tranexamic acid, 3-10% of nicotinamide, 1-5% of sodium hyaluronate, 1-5% of oligopeptide, 0.1-3% of N-acetylglucosamine, 78-4% of vitamin C1, 1-5% of ferulic acid, 2-5% of beta-glucan and the balance of water.
2. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 2-3% of abalone extract, 0.1-0.5% of abalone essential oil, 0.7-1.2% of bighead atractylodes rhizome extract, 0.6-0.8% of oat kernel extract, 0.2-1.1% of glabrous licorice root extract, 0.5-0.9% of lily extract, 0.3-0.6% of polygonatum extract, 0.2-0.4% of licorice extract, 0.6-0.8% of chamomile extract, 2-4% of tranexamic acid, 3-6% of nicotinamide, 1-2% of sodium hyaluronate, 1-2% of oligopeptide, 0.1-1.8% of N-acetylglucosamine, 1-2% of vitamin C, 1.1-1.9% of ferulic acid, 2-2.5% of beta-glucan and the balance of water.
3. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 1-2% of abalone extract, 0.2-0.3% of abalone essential oil, 0.2-0.7% of bighead atractylodes rhizome extract, 0.5-0.6% of oat kernel extract, 0.4-1.1% of glabrous licorice root extract, 0.6-0.8% of lily extract, 0.2-0.6% of polygonatum odoratum extract, 0.1-0.3% of licorice root extract, 0.8-0.9% of chamomile extract, 2-3% of tranexamic acid, 8-10% of nicotinamide, 1-3% of sodium hyaluronate, 3-5% of oligopeptide, 0.15-2% of N-acetylglucosamine, 2-3% of vitamin C, 3-5% of ferulic acid, 3-5% of beta-glucan and the balance of water.
4. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 1-2% of abalone extract, 0.5-0.9% of abalone essential oil, 0.8-1.0% of bighead atractylodes rhizome extract, 0.8-0.9% of oat kernel extract, 0.4-1.0% of glycyrrhiza glabra extract, 0.6-0.8% of lily extract, 0.2-0.6% of polygonatum odoratum extract, 0.1-0.3% of liquorice extract, 0.8-0.9% of chamomile extract, 2-3% of tranexamic acid, 3-4% of nicotinamide, 1-3% of sodium hyaluronate, 2-3% of oligopeptide, 0.15-2% of N-acetylglucosamine, 1-2% of vitamin C, 1.1-3% of ferulic acid, 2-2.5% of beta-glucan and the balance of water.
5. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 2-3% of abalone extract, 0.3-0.5% of abalone essential oil, 0.1-1.5% of bighead atractylodes rhizome extract, 0.6-0.8% of oat kernel extract, 0.2-0.4% of glabrous licorice root extract, 0.5-0.6% of lily extract, 0.2-0.3% of polygonatum odoratum extract, 0.4-0.5% of licorice root extract, 0.8-1% of chamomile extract, 4-5% of tranexamic acid, 4-6% of nicotinamide, 2-3% of sodium hyaluronate, 3-5% of oligopeptide, 2-3% of N-acetylglucosamine, 3-4% of vitamin C, 1.1-3% of ferulic acid, 2.5-3% of beta-glucan and the balance of water.
6. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.1% of abalone essential oil, 1.5% of bighead atractylodes rhizome extract, 0.5% of oat kernel extract, 3% of glabrous greenbrier rhizome extract, 0.5% of lily bulb extract, 0.7% of fragrant solomonseal rhizome extract, 0.1% of liquorice extract, 0.6% of chamomile extract, 1% of tranexamic acid, 10% of nicotinamide, 1% of sodium hyaluronate, 5% of oligopeptide, 3% of N-acetylglucosamine, 4% of vitamin C, 5% of ferulic acid, 5% of beta-glucan and the balance of water.
7. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 2% of abalone extract, 0.5% of abalone essential oil, 1.2% of bighead atractylodes rhizome extract, 0.8% of oat kernel extract, 0.2% of glabrous greenbrier rhizome extract, 0.9% of lily bulb extract, 0.6% of fragrant solomonseal rhizome extract, 0.2% of liquorice extract, 0.8% of chamomile extract, 4% of tranexamic acid, 6% of nicotinamide, 2% of sodium hyaluronate, 1% of oligopeptide, 0.1% of N-acetylglucosamine, vitamin C2%, 1.9% of ferulic acid, 2.5% of beta-glucan and the balance of water.
8. The whitening and soothing mask of claim 1, wherein: the essence comprises the following components in percentage by weight: 1% of abalone extract, 0.5% of abalone essential oil, 1.0% of bighead atractylodes rhizome extract, 0.9% of oat kernel extract, 0.4% of glabrous greenbrier rhizome extract, 0.6% of lily bulb extract, 0.2% of fragrant solomonseal rhizome extract, 0.3% of liquorice extract, 0.9% of chamomile extract, 3% of tranexamic acid, 3% of nicotinamide, 3% of sodium hyaluronate, 3% of oligopeptide, 0.15% of N-acetylglucosamine, vitamin C1%, 1.1% of ferulic acid, 2% of beta-glucan and the balance of water.
9. The whitening and soothing mask of claim 1, wherein: the said Pleurotus Ostreatus extract and Pleurotus Ostreatus essential oil are both obtained from Pleurotus Ostreatus in Shandong province.
10. The whitening and soothing mask of claim 1, wherein: the facial mask cloth is one of non-woven fabric, silk, plant fiber and superfine fiber membrane cloth.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010497538.3A CN111603427A (en) | 2020-06-04 | 2020-06-04 | Whitening and relieving mask |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010497538.3A CN111603427A (en) | 2020-06-04 | 2020-06-04 | Whitening and relieving mask |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111603427A true CN111603427A (en) | 2020-09-01 |
Family
ID=72202372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010497538.3A Pending CN111603427A (en) | 2020-06-04 | 2020-06-04 | Whitening and relieving mask |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111603427A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115154359A (en) * | 2022-07-28 | 2022-10-11 | 广州樊文花化妆品有限公司 | Whitening composition containing eutectic compound of nicotinamide and ferulic acid as well as preparation method and application of whitening composition |
| CN117180153A (en) * | 2023-09-08 | 2023-12-08 | 广州研柔慕化妆品有限公司 | Whitening composition and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101229104A (en) * | 2008-02-03 | 2008-07-30 | 大连医科大学附属第二医院 | Application of N-acetylglucosamine as white-makeup |
| US20130195925A1 (en) * | 2011-11-03 | 2013-08-01 | Vaskin, Llc | Anti aging application and method for treating aging |
| CN104758225A (en) * | 2015-03-17 | 2015-07-08 | 欧诗漫生物股份有限公司 | Skin-whitening essence liquid and preparation method thereof |
| CN109010134A (en) * | 2018-09-10 | 2018-12-18 | 南京理工大学泰州科技学院 | Self nursing type pure plant of Whitening, spot compounding oil and its application method |
| CN110917051A (en) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | Whitening essence and preparation method thereof |
-
2020
- 2020-06-04 CN CN202010497538.3A patent/CN111603427A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101229104A (en) * | 2008-02-03 | 2008-07-30 | 大连医科大学附属第二医院 | Application of N-acetylglucosamine as white-makeup |
| US20130195925A1 (en) * | 2011-11-03 | 2013-08-01 | Vaskin, Llc | Anti aging application and method for treating aging |
| CN104758225A (en) * | 2015-03-17 | 2015-07-08 | 欧诗漫生物股份有限公司 | Skin-whitening essence liquid and preparation method thereof |
| CN109010134A (en) * | 2018-09-10 | 2018-12-18 | 南京理工大学泰州科技学院 | Self nursing type pure plant of Whitening, spot compounding oil and its application method |
| CN110917051A (en) * | 2019-11-07 | 2020-03-27 | 泉后(广州)生物科技研究院有限公司 | Whitening essence and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 三彩文化: "《精油芳疗养生事典》", 30 September 2005, 汕头大学出版社 * |
| 周毅: "《达脸》", 31 January 2018, 江苏凤凰文艺出版社 * |
| 山东哈工生物科技有限公司: ""泉智方鲍芹精华精致焕颜面膜"", 《国产非特殊用途化妆品备案》 * |
| 裘炳毅等: "《现代化妆品科学与技术》", 31 March 2016, 中国轻工业出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115154359A (en) * | 2022-07-28 | 2022-10-11 | 广州樊文花化妆品有限公司 | Whitening composition containing eutectic compound of nicotinamide and ferulic acid as well as preparation method and application of whitening composition |
| CN117180153A (en) * | 2023-09-08 | 2023-12-08 | 广州研柔慕化妆品有限公司 | Whitening composition and preparation method and application thereof |
| CN117180153B (en) * | 2023-09-08 | 2024-03-22 | 广州维特丝化妆品有限公司 | Whitening composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105434256B (en) | Natural emulsion, preparation method and application thereof | |
| CN104434731B (en) | Nutritional nourishing hand cream and preparation method thereof | |
| CN108815072B (en) | Fresh plant composition fermented raw pulp with moisturizing and relieving effects and preparation method and application thereof | |
| CN113181089B (en) | Soothing and repairing composition and preparation method and application thereof | |
| CN109223681A (en) | A kind of multiple-effect skin care compositions and the application in cosmetics | |
| CN110420143A (en) | A kind of condensation and preparation method thereof containing nine grades of rank in the feudal regimes perfume Flos Nelumbinis extract | |
| CN111603427A (en) | Whitening and relieving mask | |
| KR100820009B1 (en) | Anti-oxidant and anti-inflammatory chinese cosmetic composition comprising diospyros kaki, glycyrrhiza glabra, opuntia ficus-indica, and morus alba and method for preparing the same | |
| CN110585044B (en) | Compound traditional Chinese medicine composition containing dendrobium stem and preparation method thereof | |
| CN108451847A (en) | Facial mask liquid and its preparation method and application containing dendrobium candidum extract | |
| CN106420536A (en) | Hydrated cream and preparation method thereof | |
| CN110302064B (en) | Whitening and moisturizing essence and whitening and moisturizing mask prepared from same | |
| CN108420778A (en) | A kind of composition and its application with white-skinned face function | |
| CN103550128A (en) | Skin beautifying and moistening gel and preparation method thereof | |
| CN112137919B (en) | Application of dictyophora indusiata egg extract in preparation of external beauty and skin care products and external beauty and skin care products based on same | |
| CN111374935A (en) | Polypeptide-containing composition and application thereof | |
| CN108703911B (en) | Composition with moisturizing and whitening effects and preparation method and application thereof | |
| CN111281844A (en) | Compound natural extract spot-fading mask and preparation method thereof | |
| CN107898749B (en) | A topical composition with skin caring effect and its preparation method | |
| CN105441230A (en) | Camellia oil cold processed soap | |
| KR20120043254A (en) | Cosmetic pack composition containing jeju scoria powder | |
| KR20100010315A (en) | Cosmetic composition inhibiting skin aging and wrinkle formation | |
| CN108498380A (en) | A kind of hops facial mask and preparation method thereof | |
| CN108904429A (en) | A kind of dendrobium candidum anti-ageing face mask and preparation method thereof | |
| CN110664700B (en) | Composition and application thereof in preparation of product for preventing and treating acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200901 |
|
| RJ01 | Rejection of invention patent application after publication |